Medical Pharmaceuticals

Dr. Kieran Murphy Presents Results of Clinical Trial Demonstrating Positive Effect Protecting DNA From Radiation Exposure

by

TORONTO, May 27, 2023 /PRNewswire/ — Cora Therapeutics, a dynamic life sciences startup based in Toronto, proudly unveils the results of a clinical trial at the Canadian Association of Interventional Radiologists (CAIR) annual meeting in Quebec City. Dr. Kieran Murphy MD, FRCPC, FSIR, Founder, Inventor, and CMO of Cora Therapeutics, announced the efficacy of a … Read more

Menarini Group compartilha nova análise do estudo clínico EMERALD do ORSERDU® (Elacestrant) em câncer de mama metastático na ASCO 2023

by

ORSERDU (elacestrant) foi aprovado em janeiro de 2023 pelo FDA para câncer de mama avançado ou metastático positivo para receptor de estrogênio (ER), receptor 2 do fator de crescimento epidérmico humano (HER2) negativo com mutações ESR1 (ESR1-mut), que são encontradas em até 40% dos tumores  Em pacientes cujos tumores abrigam ESR1-mut, uma análise post-hoc anterior … Read more

More than Half of Employees Delayed Necessary Medical Care due to Cost, 42% Delayed due to No Appointments Available, According to Integrated Benefits Institute Analysis

by

Individuals with more underlying chronic health conditions were more likely to delay or avoid medical care OAKLAND, Calif., May 26, 2023 /PRNewswire/ — At the height of the pandemic, individuals were asked to delay preventive care and elective procedures to alleviate incidences of community transmission. Many employers are now understandably concerned about the costs of … Read more

FDA Roundup: May 26, 2023

by

SILVER SPRING, Md., May 26, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Thursday, the FDA issued warning letters to firms responsible for two popular flavored, disposable e-cigarette products—Shenzen Innokin Technology Co. Ltd., who make Esco Bars products, and Breeze Smoke … Read more

Resolutions of Bioretec Ltd´s Annual General Meeting and the constitutive meeting of the Board of Directors

by

TAMPERE, Finland, May 26, 2023 /PRNewswire/ — The Annual General Meeting of Bioretec Ltd was held on 26 May 2023 in Tampere, Finland. The Annual General Meeting approved the financial statements for the financial year 1 January-31 December 2022 and resolved to discharge the members of the Board of Directors and the CEO from liability … Read more

International Multicultural Healthcare Thought Leader Sheila Thorne Honored as 2023 Healthcare Hero by Schneps Media

by

NEW YORK, May 26, 2023 /PRNewswire/ — Sheila Thorne, CEO and President of Multicultural Healthcare Marketing Group (MHMG), has been recognized as a 2023 Healthcare Hero by Schneps Media. This prestigious award honors Thorne’s outstanding contributions and leadership in cultural competency in healthcare from molecule to market. Sheila Thorne, CEO and President of Multicultural Healthcare Marketing Group … Read more

Sector is Expected to Reach $9.8 Billion by 2032 at a CAGR of 12.57%

by

DUBLIN, May 26, 2023 /PRNewswire/ — The “Next-Generation Breast Cancer Diagnostic and Screening Market – A Global Market and Regional Analysis: Focus on Technology, Cancer Sub-Type, Biomarker, Offering, End User, and Country Analysis – Analysis and Forecast, 2023-2032” report has been added to ResearchAndMarkets.com’s offering. The global next-generation breast cancer diagnostic and screening market was … Read more

Pulse Medical receives FDA Breakthrough Device Designation for its μFR® system

by

SHANGHAI, May 26, 2023 /PRNewswire/ — Pulse Medical Technology, Inc. (Pulse Medical) 4th generation μFR® system has received an FDA Breakthrough Device designation.  Pulse Medical, founded in 2015, located in Shanghai, China, is dedicated to developing innovative technology for precise diagnosis and optimal treatment of patients with pan-vascular disease. Pulse Medical has been pioneering and … Read more

Novavax’s Nuvaxovid™ Receives Positive CHMP Opinion for Full Marketing Authorization for the Prevention of COVID in the EU

by

GAITHERSBURG, Md., May 26, 2023 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that Nuvaxovid™ (NVX-CoV2373) has been recommended for full Marketing Authorization (MA) for use as a primary series in individuals aged 12 and older and as a booster in individuals aged 18 … Read more

ProfoundBio Announces Further Advancement of Lead Programs

by

PRO1160 first patient dosed in the US China NMPA clearance for PRO1184 (rinatabart sesutecan, Rina-S) and PRO1160 to initiate clinical trials Rina-S preliminary clinical data is encouraging SUZHOU, China and WOODINVILLE, Wash., May 26, 2023 /PRNewswire/ — ProfoundBio, a clinical-stage biotechnology company focused on the development of novel antibody-based therapeutics, announced that dosing in the Phase … Read more